Latest News and Press Releases
Want to stay updated on the latest news?
-
COPENHAGEN, Denmark and BOSTON, Dec. 05, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR) today announced that Mr. Nis Kruse joined the Company as EVP of Strategic...
-
December 5, 2022News Release BioPorto adds Mr. Nis Kruse as EVP of Strategic Partnerships and GM of EMEA & APAC COPENHAGEN, DENMARK and BOSTON, MA, December 5, 2022, (GLOBE NEWSWIRE)...
-
November 23, 2022 Announcement no. 17 Resolutions of the Extraordinary General Meeting of BioPorto A/S COPENHAGEN, DENMARK and BOSTON, MA, USA, November 23, 2022, (GLOBE NEWSWIRE) -- BioPorto A/S...
-
November 10, 2022 Announcement no. 16 BioPorto Submits Application for Marketing Authorization of NGAL Test to the US Food and Drug Administration COPENHAGEN, DENMARK and BOSTON, MA, USA,...
-
November 10, 2022 Announcement no. 16 BioPorto Submits Application for Marketing Authorization of NGAL Test to the US Food and Drug Administration COPENHAGEN, DENMARK and BOSTON, MA, USA, November...
-
Announcement no. 15 COPENHAGEN, Denmark and BOSTON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced interim financial results for the first nine months of...
-
November 9, 2022 Announcement no. 15 BioPorto Announces Interim Results for the First Nine Months of 2022 COPENHAGEN, Denmark and BOSTON, MA, USA, November 9, 2022, (GLOBE NEWSWIRE) -- BioPorto A/S...
-
COPENHAGEN, Denmark and BOSTON, Nov. 03, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of kidney injury,...
-
November 3, 2022News release BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call COPENHAGEN, DENMARK and BOSTON, MA, USA, November 3, 2022, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto)...
-
November 1, 2022 Announcement no. 14 NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING In accordance with Article 5 of the Articles of Association, the Board of Directors hereby...